{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:16:27Z","timestamp":1790770587272,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00417-024-06491-0","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T09:02:01Z","timestamp":1713517321000},"page":"2999-3006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Teprotumumab improves light sensitivity in patients with thyroid eye disease"],"prefix":"10.1007","volume":"262","author":[{"given":"Emanuil","family":"Parunakian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Ugradar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tolentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Malkhasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pershanjit","family":"Raika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"6491_CR1","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","volume":"181","author":"S Tsui","year":"2008","unstructured":"Tsui S, Naik V, Hoa N et al (2008) Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in graves\u2019 disease. J Immunol 181:4397\u20134405. https:\/\/doi.org\/10.4049\/jimmunol.181.6.4397","journal-title":"J Immunol"},{"key":"6491_CR2","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1038\/s41433-020-01297-w","volume":"35","author":"S Ugradar","year":"2021","unstructured":"Ugradar S, Shi L, Wang Y et al (2021) Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression. Eye 35:2607\u20132612. https:\/\/doi.org\/10.1038\/s41433-020-01297-w","journal-title":"Eye"},{"key":"6491_CR3","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG et al (2017) Teprotumumab for thyroid-associated Ophthalmopathy. N Engl J Med 376:1748\u20131761. https:\/\/doi.org\/10.1056\/NEJMoa1614949","journal-title":"N Engl J Med"},{"key":"6491_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMOA1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A et al (2020) Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 382:341\u2013352. https:\/\/doi.org\/10.1056\/NEJMOA1910434","journal-title":"N Engl J Med"},{"key":"6491_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41433-021-01593-z","volume":"36","author":"S Ugradar","year":"2022","unstructured":"Ugradar S, Kang J, Kossler AL et al (2022) Teprotumumab for the treatment of chronic thyroid eye disease. Eye (Lond) 36:1553\u20131559. https:\/\/doi.org\/10.1038\/s41433-021-01593-z","journal-title":"Eye (Lond)"},{"key":"6491_CR6","doi-asserted-by":"publisher","unstructured":"Douglas RS, Couch S, Wester ST et al (2023) Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity. J Clin Endocrinol Metab 109:25\u201335. https:\/\/doi.org\/10.1210\/clinem\/dgad637","DOI":"10.1210\/clinem\/dgad637"},{"key":"6491_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s40123-021-00385-8","volume":"10","author":"KP Cockerham","year":"2021","unstructured":"Cockerham KP, Padnick-Silver L, Stuertz N et al (2021) Quality of life in patients with chronic thyroid eye disease in the United States. Ophthalmol Ther 10:975\u2013987. https:\/\/doi.org\/10.1007\/s40123-021-00385-8","journal-title":"Ophthalmol Ther"},{"key":"6491_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ceo.14208","volume":"51","author":"S Ugradar","year":"2023","unstructured":"Ugradar S, Zimmerman E, Parunakian E et al (2023) Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab. Clin Experiment Ophthalmol 51:339\u2013348. https:\/\/doi.org\/10.1111\/ceo.14208","journal-title":"Clin Experiment Ophthalmol"},{"key":"6491_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.6.4.18","volume":"6","author":"JD Verriotto","year":"2017","unstructured":"Verriotto JD, Gonzalez A, Aguilar MC et al (2017) New methods for quantification of visual photosensitivity threshold and symptoms. Transl Vis Sci Technol 6:18. https:\/\/doi.org\/10.1167\/tvst.6.4.18","journal-title":"Transl Vis Sci Technol"},{"key":"6491_CR10","doi-asserted-by":"publisher","first-page":"100809","DOI":"10.1016\/j.ajoc.2020.100809","volume":"19","author":"N Venkateswaran","year":"2020","unstructured":"Venkateswaran N, Hwang J, Rong AJ et al (2020) Periorbital botulinum toxin a improves photophobia and sensations of dryness in patients without migraine: case series of four patients. Am J Ophthalmol Case Rep 19:100809. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100809","journal-title":"Am J Ophthalmol Case Rep"},{"key":"6491_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM et al (1989) Clinical criteria for the assessment of disease activity in graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol 73:639\u2013644. https:\/\/doi.org\/10.1136\/bjo.73.8.639","journal-title":"Br J Ophthalmol"},{"key":"6491_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.ico.0000148312.01805.53","volume":"24","author":"F R\u00fcfer","year":"2005","unstructured":"R\u00fcfer F, Schr\u00f6der A, Erb C (2005) White-to-white corneal diameter. Cornea 24:259\u2013261. https:\/\/doi.org\/10.1097\/01.ico.0000148312.01805.53","journal-title":"Cornea"},{"key":"6491_CR13","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1167\/iovs.10-5380","volume":"51","author":"E Villani","year":"2010","unstructured":"Villani E, Viola F, Sala R et al (2010) Corneal involvement in graves\u2019 Orbitopathy: an in vivo confocal study. Investigative Opthalmology & Visual Science 51:4574. https:\/\/doi.org\/10.1167\/iovs.10-5380","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"6491_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/02713683.2015.1133833","volume":"41","author":"L-Q Wu","year":"2016","unstructured":"Wu L-Q, Cheng J-W, Cai J-P et al (2016) Observation of corneal Langerhans cells by in vivo confocal microscopy in thyroid-associated Ophthalmopathy. Curr Eye Res 41:927\u2013932. https:\/\/doi.org\/10.3109\/02713683.2015.1133833","journal-title":"Curr Eye Res"},{"key":"6491_CR15","doi-asserted-by":"publisher","first-page":"103592","DOI":"10.1016\/j.pdpdt.2023.103592","volume":"42","author":"M Oklar","year":"2023","unstructured":"Oklar M, Yazicioglu T, Ozen MC et al (2023) Evaluation of corneal endothelium and correlation with disease severity in patients with graves\u2019 ophthalmopathy: a specular microscopy-based study. Photodiagn Photodyn Ther 42:103592. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103592","journal-title":"Photodiagn Photodyn Ther"},{"key":"6491_CR16","doi-asserted-by":"publisher","first-page":"e42483","DOI":"10.1371\/journal.pone.0042483","volume":"7","author":"Y-C Wu","year":"2012","unstructured":"Wu Y-C, Zhu M, Robertson DM (2012) Novel nuclear localization and potential function of insulin-like growth Factor-1 receptor\/insulin receptor hybrid in corneal epithelial cells. PLoS One 7:e42483. https:\/\/doi.org\/10.1371\/journal.pone.0042483","journal-title":"PLoS One"},{"key":"6491_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/exer.1999.0775","volume":"70","author":"M Nakamura","year":"2000","unstructured":"Nakamura M, Chikama T-I, Nishida T (2000) Characterization of insulin-like growth Factor-1 receptors in rabbit corneal epithelial cells. Exp Eye Res 70:199\u2013204. https:\/\/doi.org\/10.1006\/exer.1999.0775","journal-title":"Exp Eye Res"},{"key":"6491_CR18","unstructured":"Rocha EM, Cunba DA, Carneiro EM et al (2002) Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci 43"},{"key":"6491_CR19","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1038\/s41598-018-21031-7","volume":"8","author":"R Titone","year":"2018","unstructured":"Titone R, Zhu M, Robertson DM (2018) Insulin mediates de novo nuclear accumulation of the IGF-1\/insulin hybrid receptor in corneal epithelial cells. Sci Rep 8:4378. https:\/\/doi.org\/10.1038\/s41598-018-21031-7","journal-title":"Sci Rep"},{"key":"6491_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exer.2011.12.006","volume":"94","author":"DM Robertson","year":"2012","unstructured":"Robertson DM, Zhu M, Wu Y-C (2012) Cellular distribution of the IGF-1R in corneal epithelial cells. Exp Eye Res 94:179\u2013186. https:\/\/doi.org\/10.1016\/j.exer.2011.12.006","journal-title":"Exp Eye Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06491-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06491-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T14:11:41Z","timestamp":1725545501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06491-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["6491"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06491-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the private practice of Dr. Raymond Douglas and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The study was approved by the WCG-IRB (WCG, Puyallup, WA, USA) institutional review board (IRB No. 20210376).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial support"}},{"value":"Raymond Douglas is an employee of Sling Therapeutics. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}